Published Paper Details:

Natural products have long been a rich source of bioactive compounds, contributing significantly to the development of modern drugs. In the face of emerging global health challenges, these compounds remain a cornerstone in drug discovery, offering unique molecular scaffolds and complex structures that are often difficult to synthesize artificially. Historically, natural products have led to the discovery of numerous therapeutic agents, including antibiotics, anticancer drugs, and immune-suppressants. Their ability to interact with biological targets in diverse and often highly specific ways makes them invaluable in the design of novel drugs.Recent advancements in biotechnology, genomics, and high-throughput screening have enhanced our ability to identify and characterize potential drug candidates from natural sources. In particular, natural products derived from plants, microorganisms, and marine organisms continue to provide new leads for combating diseases such as cancer, infectious diseases, and neurodegenerative disorders. Additionally, the growing understanding of natural product biosynthesis pathways has opened new avenues for optimizing yields and creating novel derivatives with improved potency and selectivity.Despite the tremendous promise of natural products, challenges remain in terms of sustainable sourcing, scalability, and regulatory hurdles. However, with continued research and innovation, natural products are poised to remain a fundamental part of modern drug development. This review highlights the enduring importance of natural products in pharmaceutical discovery, emphasizing their role in shaping the future of medicine and their continued relevance in addressing unmet medical needs.